Monday, September 23, 2019
- 1:45pm-3:15pm
-
“So much easier”; patient’s perceptions of Virtual Clinics for Parkinson’s Disease
Quality of Life · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
3 Year QoL Results for PD Patients Receiving DBS: Product Surveillance Registry
Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
5 cases Static Encephalopathy of childhood with NeuroDegeneration in Adulthood (OMIM 300894) in children
Rare Genetic and Metabolic Diseases · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
7,8- Dihydroxyflavone prevents 3-NitropropionicAcid (3-NP)-induced Striatal Toxicity by Modulating the TrkB receptor and Microglial Activation Pathway
Huntington’s Disease · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
A case of Aceruloplasminemia with vertical saccadic eye movement abnormalities
Rare Genetic and Metabolic Diseases · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
A case of cerebellar ataxia caused by Pembrolizumab for Non-small cell lung cancer
Ataxia · Les Muses, Level 3
- 1:45pm-3:15pm
-
A Case of Diurnally Variable Gut Discomfort in a Patient with RLS
Restless Leg Syndrome, RBD and Other Sleep Disorders · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
A case of hemimasticatory spasm with well therapeutic response to serial injections of botulinum toxin
Other · Agora 2 West, Level 2
- 1:45pm-3:15pm
-
A Case of Secondary Myoclonic Hyperkinesia
Myoclonus · Les Muses, Level 3
- 1:45pm-3:15pm
-
A Case Presentation of Wilson’s Disease
Ataxia · Les Muses, Level 3
- 1
- 2
- 3
- …
- 75
- Next Page»